Back HIV/AIDS HIV/AIDS Topics HIV Prevention

Is an HIV Vaccine Necessary to End AIDS?

Expanded access to antiretroviral therapy for treatment and prevention, along with other proven prevention strategies, could conceivably end the HIV/AIDS epidemic, but goal would be achieved much faster if an even modestly effective HIV vaccine were available, Anthony Fauci and Hilary Marston from the National Institutes of Allergy and Infectious Diseases (NIAID) wrote in the February 6 New England Journal of Medicine.

alt

Read more:

Studies Shed Light on Sexual Transmission of HIV Among Young Gay Men

Young men who have sex with men tend to have higher HIV viral load compared with heterosexuals, contributing to a greater likelihood of transmission, according to a recent report. Another recent study offers more information on the risk of HIV transmission associated with specific sexual activities in the absence of antiretroviral treatment.

alt

Read more:

HIVandHepatitis.com Complete 2013 Conference Coverage

HIVandHepatitis.com 2013 conference and meeting coverage.

Full conference listing

12/30/13

alt

 

 

Most U.S. Providers Support PrEP, but Not Many Have Prescribed It

About three-quarters of infectious disease physicians in North America said they favored HIV pre-exposure prophylaxis (PrEP), but only 9% reported that they had prescribed Truvada (tenofovir/emtricitabine) for this purpose, according to a report in the December 6, 2013, advance edition of Clinical Infectious Diseases.

alt

Read more:

PrEP Does Not Promote Increased Sexual Risk Behavior among Gay Men

Using Truvada (tenofovir/emtricitabine) for pre-exposure prophylaxis (PrEP) to prevent HIV infection was not associated with an increase in sex without condoms and it appears to promote active engagement in risk reduction, according to a report in the December 18, 2013, edition of PLoS ONE.

alt

Read more: